BioSpace News Archive

Livongo Health, Inc., the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, announced financial results for its first quarter ended March 31, 2020.

Prothena Corporation plc, a clinical-stage neuroscience company with expertise in protein misfolding, reported financial results for the first quarter of 2020.

Principia Biopharma Inc., a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases, announced financial results for the first quarter ended March 31, 2020.

Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced that its management team will be presenting at the virtual UBS Global Healthcare Conference on May 20, 2020.

Pacific Biosciences of California, Inc. announced financial results for its first quarter ended March 31, 2020.

Global Blood Therapeutics, Inc. reported recent business progress and financial results for the first quarter ended March 31, 2020.

Celldex Therapeutics, Inc. reported business and financial highlights for the first quarter ended March 31, 2020.

OPKO Health, Inc. reports business highlights and financial results for the three months ended March 31, 2020.

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, reported its financial results for the quarter ended March 31, 2020 and maintained its full year 2020 financial guidance.

GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care, announced that it has commenced an underwritten public offering of shares of its common stock.